Shown verbatim: the complete text as captured from the official page posted by the Wisconsin Legislature, fetched 2026-08-23. This is the current version. The official bill page.
2025 - 2026 LEGISLATURE LRB-2165/1 MED:skw 2025 SENATE BILL 68 February 24, 2025 - Introduced by Senator Testin, cosponsored by Representative Dittrich. Referred to Committee on Mental Health, Substance Abuse Prevention, Children and Families. An Act to amend 961.385 (2) (cs) 1., 961.385 (5) (b) and 961.385 (6) (a) of the statutes; relating to: the prescription drug monitoring program. Analysis by the Legislative Reference Bureau Current law requires the Controlled Substances Board to establish a prescription drug monitoring program (PDMP) that requires pharmacies and health care practitioners to generate records documenting the dispensing of monitored prescription drugs. Records from the PDMP may be disclosed to persons specified under current law or by the board by rule. This bill makes changes to certain requirements under the PDMP: 1. Subject to exceptions, current law requires that a patient’s records under the program be reviewed before a practitioner issues a prescription order for the patient. However, current law provides that this requirement does not apply after April 1, 2025. The bill extends the application of this requirement by five years, to April 1, 2030. 2. Current law requires the board to conduct a quarterly review of the PDMP to evaluate the actual outcomes of the PDMP compared with projected outcomes. However, current law provides that this requirement does not apply after October 30, 2025. The bill extends the application of this requirement by five years, to October 30, 2030. For further information see the state fiscal estimate, which will be printed as an appendix to this bill. The people of the state of Wisconsin, represented in senate and assembly, do enact as follows: Section 1. 961.385 (2) (cs) 1. of the statutes is amended to read: 961.385 (2) (cs) 1. Require that a patient’s records under the program be reviewed before the practitioner issues a prescription order for the patient. The review required under this subdivision may be performed by the practitioner or by the practitioner’s agent in accordance with applicable standards of practice. This subdivision does not apply after April 1, 2025 2030. Section 2. 961.385 (5) (b) of the statutes is amended to read: 961.385 (5) (b) This subsection does not apply after October 30, 2025 2030. Section 3. 961.385 (6) (a) of the statutes is amended to read: 961.385 (6) (a) The results of the board’s review under sub. (5). This paragraph does not apply after October 30, 2025 2030. (end)
Every fact on this page links to its source, starting with the official bill record.